Immunology, Interleukin 21, Cell biology, IL-2 receptor and Cytotoxic T cell are his primary areas of study. He works mostly in the field of Immunology, limiting it down to topics relating to Molecular biology and, in certain cases, Receptor and CD8, as a part of the same area of interest. Francesco Liotta combines subjects such as CCR8 and Bone marrow with his study of Cell biology.
The study incorporates disciplines such as Interleukin 2, Endocrinology and Internal medicine in addition to IL-2 receptor. His study involves Interleukin 12, Natural killer T cell and Interleukin 3, a branch of Cytotoxic T cell. In his research on the topic of Interleukin 12, T helper cell is strongly related with Antigen-presenting cell.
His main research concerns Immunology, Cell biology, IL-2 receptor, Interleukin 21 and Cytotoxic T cell. His work on MARCKS as part of general Cell biology research is frequently linked to Actin remodeling, thereby connecting diverse disciplines of science. His IL-2 receptor study incorporates themes from Interleukin 2, Endocrinology, Monoclonal antibody and FOXP3.
Francesco Liotta has researched Interleukin 21 in several fields, including T lymphocyte, CD40, Antigen-presenting cell, Interleukin 4 and Interleukin 12. In his research, CD8 is intimately related to Molecular biology, which falls under the overarching field of Cytotoxic T cell. His studies deal with areas such as Mesenchymal stem cell, Notch signaling pathway and Cell growth as well as T cell.
Francesco Liotta mainly focuses on Immunology, Immune system, Vaccination, Asymptomatic and Acquired immune system. In his works, Francesco Liotta conducts interdisciplinary research on Immunology and Synovial fluid. His Immune system research integrates issues from Statin, Interleukin 6 and Coronavirus disease 2019, Severe acute respiratory syndrome coronavirus 2.
His Acquired immune system research incorporates themes from Virus, Antibody, Cellular Immunology and Herd immunity. Francesco Liotta interconnects Inflammation and Cell biology in the investigation of issues within Cytotoxic T cell. His studies in CD8 integrate themes in fields like Immune checkpoint, T cell and Cancer research, Stromal cell.
His scientific interests lie mostly in Immunology, Vaccination, Flow cytometry, Cytotoxic T cell and Immune system. His research on Immunology often connects related areas such as Asymptomatic. His Vaccination research is multidisciplinary, relying on both Immune checkpoint, Blockade, Cancer, Acquired immune system and Cellular Immunology.
In general Flow cytometry, his work in Cell sorting and Cell separation is often linked to Cell selection and Data science linking many areas of study. Francesco Liotta has included themes like Cytokine, Phenotype, Secretion, Transcription factor and Cell biology in his Cytotoxic T cell study. The Immune system study combines topics in areas such as Interleukin 6, Virus and Antibody.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Phenotypic and functional features of human Th17 cells.
Francesco Annunziato;Lorenzo Cosmi;Veronica Santarlasci;Laura Maggi.
Journal of Experimental Medicine (2007)
Role for Interferon-γ in the Immunomodulatory Activity of Human Bone Marrow Mesenchymal Stem Cells
Mauro Krampera;Lorenzo Cosmi;Roberta Angeli;Annalisa Pasini.
Stem Cells (2006)
Human interleukin 17-producing cells originate from a CD161+CD4+ T cell precursor.
Lorenzo Cosmi;Raffaele De Palma;Veronica Santarlasci;Laura Maggi.
Journal of Experimental Medicine (2008)
Isolation and Characterization of Multipotent Progenitor Cells from the Bowman’s Capsule of Adult Human Kidneys
Costanza Sagrinati;Giuseppe Stefano Netti;Benedetta Mazzinghi;Elena Lazzeri.
Journal of The American Society of Nephrology (2006)
Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)
Andrea Cossarizza;Hyun Dong Chang;Andreas Radbruch;Andreas Acs.
European Journal of Immunology (2019)
Toll-Like Receptors 3 and 4 Are Expressed by Human Bone Marrow-Derived Mesenchymal Stem Cells and Can Inhibit Their T-Cell Modulatory Activity by Impairing Notch Signaling
Francesco Liotta;Roberta Angeli;Lorenzo Cosmi;Lucia Filì.
Stem Cells (2008)
Phenotype, localization, and mechanism of suppression of CD4(+)CD25(+) human thymocytes.
Francesco Annunziato;Lorenzo Cosmi;Francesco Liotta;Elena Lazzeri.
Journal of Experimental Medicine (2002)
Human CD8+CD25+ thymocytes share phenotypic and functional features with CD4+CD25+ regulatory thymocytes
Lorenzo Cosmi;Francesco Liotta;Elena Lazzeri;Michela Francalanci.
Th17 cells: new players in asthma pathogenesis.
Lorenzo Cosmi;Francesco Liotta;Enrico Maggi;Sergio Romagnani.
CD161 is a marker of all human IL-17-producing T-cell subsets and is induced by RORC
Laura Maggi;Veronica Santarlasci;Manuela Capone;Anna Peired.
European Journal of Immunology (2010)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: